Garrido, P. http://orcid.org/0000-0002-5899-6125
Hladun, R.
de Álava, E.
Álvarez, R.
Bautista, F.
López-Ríos, F.
Colomer, R.
Rojo, F.
Article History
Received: 30 November 2020
Accepted: 24 January 2021
First Online: 23 February 2021
Compliance with ethical standards
:
: The authors declare that, when writing and revising the text, they did not know the names of the pharmaceutical companies that provided financial support for this project, so this support has not influenced the content of this article. P Garrido declared advisory and consultancy honoraria from AbbVie, AstraZeneca, Blue-Print Medicines, BMS, Boehringer Ingelheim, Janssen, Lilly, MSD, Novartis, Pfizer, Roche and Takeda; was compensated as speaker by AstraZeneca, BMS, Boehringer Ingelheim, Janssen, Gilead, MSD, Pfizer, Roche, Rovi and Takeda. R Hladun declared she has not conflict of interest. E de Álava declared advisory and consultancy honoraria from Bayer, Lilly, and Roche; and was compensated as speaker by PharmaMar. R Álvarez declared advisory and consultancy honoraria from Boehringer Ingelheim, Lilly and PharmaMar; was compensated as speaker by Bayer, BMS, MSD, Novartis, PharmaMar and Roche; received research grants from Abbvie, AstraZeneca, Blue-Print Medicines, BMS, Janssen, Merrimack, Novartis, MSD, PharmaMar, Roche and Takeda; and benefitted from travel and accommodation expenses funded by PharmaMar and Roche. F Bautista declared advisory and consultancy honoraria from Amgen, Bayer, Eusa Pharma and Sanofi; was compensated as speaker by Amgen and Jazz Pharmaceuticals; and benefitted from travel and accommodation expenses funded by Eusa Pharma, Jazz Pharmaceuticals, Shire and Takeda. F López-Ríos declared advisory and consultancy honoraria from AstraZeneca, Bayer, BMS, Life Technologies, Lilly, MSD, Pfizer and Roche; and received research grants from Life Technologies, Lilly and Roche. R Colomer declared advisory and consultancy honoraria from Lilly, MSD, Roche and Servier; and was compensated as speaker by AstraZeneca, BMS, Janssen, Lilly, MSD, Novartis, Pfizer, and Roche. F Rojo declared advisory and consultancy honoraria from Archer, AstraZeneca, BMS, Genomic Health, Guardant Health, Lilly, MSD, Novartis, Pfizer, Pierre-Fabre and Roche; was compensated as speaker by AstraZeneca, BMS, Lilly, MSD, Novartis, Pfizer, Pierre-Fabre and Roche; received research grants from Pfizer and Roche; and benefitted from travel and accommodation expenses funded by Novartis and Roche.
: The study has been performed in accordance with the ethical standards of the Declaration of Helsinki and its later amendments. This article does not contain any studies with human participants or animals performed by any of the authors.
: For this type of study, formal consent is not required.